Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Rifabutin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,547Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RedHill's Talicia Listed As First-Line For H. Pylori In ACG Guidelines
    RedHill's Talicia Listed As First-Line For H. Pylori In ACG Guidelines

    09 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/redhills-talicia-listed-as-first-line-choice-for-h-pylori-in-new-american-college-of-gastroenterology-guidelines-302241849.html

    PR NEWSWIRE
    09 Sep 2024
    Share Share
    RedHill Biopharma and Gaelan Medical Enter Into License Agreement for Talicia
    RedHill Biopharma and Gaelan Medical Enter Into License Agreement for Talicia

    06 Jan 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/redhill-biopharma-and-gaelan-medical-enter-into-license-agreement-for-talicia-for-the-united-arab-emirates-301455477.html

    PRNEWSWIRE
    06 Jan 2022
    Share Share
    ANI Announces FDA Approval and Imminent Launch of Rifabutin Capsules USP
    ANI Announces FDA Approval and Imminent Launch of Rifabutin Capsules USP

    21 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211221005173/en

    BUSINESSWIRE
    21 Dec 2021
    Share Share
    Novitium Pharma's Generic Rifabutin Receives Approval in the U.S.
    Novitium Pharma's Generic Rifabutin Receives Approval in the U.S.

    17 Dec 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215041

    FDA
    17 Dec 2021
    Share Share
    RedHill Biopharma Presents New Talicia® and Movantik® Data Analyses at ACG 2021
    RedHill Biopharma Presents New Talicia® and Movantik® Data Analyses at ACG 2021

    25 Oct 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/redhill-biopharma-presents-new-talicia-and-movantik-data-analyses-at-acg-2021-301407403.html

    PRNEWSWIRE
    25 Oct 2021
    Share Share
    RedHill Biopharma Announces Talicia(R) added to Medi-Cal CDL
    RedHill Biopharma Announces Talicia(R) added to Medi-Cal CDL

    06 Oct 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/redhill-biopharma-ltd-announces-talicia-r-added-to-medi-cal-cdl/?s=71

    BIOSPACE
    06 Oct 2021
    Share Share